Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, December 21, 2014
Technology Networks
Register | Sign in
Home Page>Products>Product Directory
  Product Directory

C18 nec (23%) 2mL/200mg
Greyhound Chromatography - Products
C18 nec (23%) 2mL/50mg
Greyhound Chromatography - Products
C18 nec (23%) 300mg
Greyhound Chromatography - Products
C18 nec (23%) 3mL/200mg
Greyhound Chromatography - Products
C18 nec (23%) 3mL/500mg
Greyhound Chromatography - Products
C18 nec (23%) 600mg
Greyhound Chromatography - Products
C18 nec (23%) 6mL/1g
Greyhound Chromatography - Products
C18 nec (23%) 6mL/2g
Greyhound Chromatography - Products
C18 nec (23%) 6mL/500mg
Greyhound Chromatography - Products
C18 nec (23%) 900mg
Greyhound Chromatography - Products
<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 95
Scientific News
Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes
Promising profile of disease modification and pain reduction leads to proof of concept trials.
Barrier-Breaking Drug May Lead to Spinal Cord Injury Treatments
NIH-funded scientists take first step towards developing promising new drug.
Two Drugs are No More Effective Than One to Treat Common Kidney Disease
NIH study finds limited kidney benefit from more rigorous blood pressure treatment.
Antibiotic Resistance Threatens Future of Modern Medicine
Overuse and misuse of antibiotics, one of the key contributors to antimicrobial resistance (AMR).
Computer Model Sets New Precedent in Drug Discovery
New computational model can precisely simulate, predict therapeutic protein behaviors to help zero in on ideal drug design candidates.
New Drug for Common Liver Disease Improves Liver Health
An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the NIH.
'Rewriting' the Way to Make Natural Drug Compounds
Using an organism's own pathway to synthesize potential therapeutics.
MS Drug Candidate Shows Promise for Ulcerative Colitis
Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute.
New Technique has Profound Implications for Drug Development
The method, developed by Scripps Research Institute chemists, expands options for making pure batches of ‘one-handed’ molecules.
Team Discovers How Microbes Build a Powerful Antibiotic
Researchers discovery opens up new avenues of research into thousands of similar molecules.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn